Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: China Clear all

126 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20111
20161
20172
20194
20207
202120
20229
202324
202415
202515
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting39
Unknown status31
Not yet recruiting24
Active, not recruiting15
Completed15
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University11
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Sun Yat-sen University9
Fudan University7
West China Hospital7
Sichuan Baili Pharmaceutical Co., Ltd.6
Cancer Institute and Hospital, Chinese Academy of Medical Sciences3
Shanghai Zhongshan Hospital3
Xuekui Liu3
Zhejiang Provincial People's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck126
Head and Neck Neoplasms17
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Triple Negative Breast Neoplasms3
Uterine Cervical Neoplasms3
Colorectal Neoplasms2
Esophageal Squamous Cell Carcinoma2
Mouth Neoplasms2
Carcinoma, Hepatocellular1

Trials

Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.

26 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.